Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.

Yioti GG, Panagiotou OA, Vartholomatos GA, Kolaitis NI, Pappa CN, Evangelou E, Stefaniotou MI.

Ophthalmic Genet. 2013 Sep;34(3):130-9. doi: 10.3109/13816810.2012.746376. Epub 2013 Jan 4.

PMID:
23289804
2.

MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.

Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C.

Clin Ter. 2003 Sep-Oct;154(5):299-303.

PMID:
14994919
3.

Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.

Russo PD, Damante G, Pasca S, Turello M, Barillari G.

Clin Appl Thromb Hemost. 2015 May;21(4):373-7. doi: 10.1177/1076029614522544. Epub 2014 Feb 25.

PMID:
24569626
4.

Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.

Kuhli-Hattenbach C, Hellstern P, Nägler DK, Kohnen T, Hattenbach LO.

Ophthalmic Genet. 2017 Sep-Oct;38(5):413-417. doi: 10.1080/13816810.2016.1244694. Epub 2017 Jan 13.

PMID:
28085526
5.

Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.

Gori AM, Marcucci R, Fatini C, Gensini F, Sticchi E, Sodi A, Cappelli S, Menchini U, Gensini GF, Abbate R, Prisco D.

Thromb Haemost. 2004 Jul;92(1):54-60.

PMID:
15213845
6.

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.

Gohil R, Peck G, Sharma P.

Thromb Haemost. 2009 Aug;102(2):360-70. doi: 10.1160/TH09-01-0013.

PMID:
19652888
7.

The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.

Jusić A, Balić D, Avdić A, Pođanin M, Balić A.

Med Glas (Zenica). 2018 Aug 1;15(2):158-163. doi: 10.17392/948-18.

8.

Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.

Pietropolli A, Giuliani E, Bruno V, Patrizi L, Piccione E, Ticconi C.

J Obstet Gynaecol. 2014 Apr;34(3):229-34. doi: 10.3109/01443615.2013.836476. Epub 2014 Jan 31.

PMID:
24484533
9.

The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.

Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C.

Eye (Lond). 2003 Aug;17(6):772-7.

PMID:
12928694
10.

Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.

Falvella FS, Cremolini C, Miceli R, Nichetti F, Cheli S, Antoniotti C, Infante G, Martinetti A, Marmorino F, Sottotetti E, Berenato R, Caporale M, Colombo A, de Braud F, Di Bartolomeo M, Clementi E, Loupakis F, Pietrantonio F.

Pharmacogenomics J. 2017 Jul;17(4):331-336. doi: 10.1038/tpj.2016.22. Epub 2016 Mar 22.

PMID:
27001121
11.

Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.

Ranellou K, Paraskeva A, Kyriazopoulos P, Batistatou A, Evangelou A, El-Aly M, Zis P, Tavernarakis A, Charalabopoulos K.

Blood Coagul Fibrinolysis. 2015 Jun;26(4):430-5. doi: 10.1097/MBC.0000000000000274.

PMID:
25699610
12.

Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women.

Chatzidimitriou M, Chatzidimitriou D, Mavridou M, Anetakis C, Chatzopoulou F, Lialiaris T, Mitka S.

Int J Lab Hematol. 2017 Dec;39(6):590-595. doi: 10.1111/ijlh.12703. Epub 2017 Jun 12.

PMID:
28603947
13.

Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.

Mrad M, Wathek C, Saleh MB, Baatour M, Rannen R, Lamine K, Gabsi S, Gritli N, Fekih-Mrissa N.

Transfus Apher Sci. 2014 Apr;50(2):283-7. doi: 10.1016/j.transci.2013.12.016. Epub 2014 Jan 8.

PMID:
24440586
14.

Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.

Mrad M, Fekih-Mrissa N, Wathek C, Rannen R, Gabsi S, Gritli N.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1592-8. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.048. Epub 2014 Mar 14.

PMID:
24630828
15.

Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?

Gokalp D, Tuzcu A, Bahceci M, Ayyildiz O, Yurt M, Celik Y, Alpagat G.

Pituitary. 2011 Jun;14(2):168-73. doi: 10.1007/s11102-010-0276-x.

PMID:
21107737
17.

A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.

Yenicesu GI, Cetin M, Ozdemir O, Cetin A, Ozen F, Yenicesu C, Yildiz C, Kocak N.

Am J Reprod Immunol. 2010 Feb;63(2):126-36. doi: 10.1111/j.1600-0897.2009.00770.x. Epub 2009 Nov 10.

PMID:
19906129
18.

The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.

Supanc V, Sonicki Z, Vukasovic I, Solter VV, Zavoreo I, Kes VB.

J Stroke Cerebrovasc Dis. 2014 Mar;23(3):e171-6. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.025. Epub 2013 Nov 1.

PMID:
24189452
19.

Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.

McGimpsey SJ, Woodside JV, Cardwell C, Cahill M, Chakravarthy U.

Ophthalmology. 2009 Sep;116(9):1778-1787.e1. doi: 10.1016/j.ophtha.2009.02.033.

PMID:
19729099
20.

Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland.

Gagala J, Buraczynska M, Mazurkiewicz T, Ksiazek A.

BMC Musculoskelet Disord. 2013 Sep 11;14:264. doi: 10.1186/1471-2474-14-264.

Supplemental Content

Support Center